VRDN R&D Expense Growth
Viridian Therapeutics Ors Inc · R&D Expense Growth
VRDN R&D Expense Growth
Latest reported42.26%period ending
VRDN FY R&D Growth (YoY) (0.00% → 42.26%)
Latest values, visible window
High-resolution chart · PNG
VRDN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 42.2553% | |
| 49.1278% | |
| 58.3494% | |
| 77.3617% | |
| 100.9822% | |
| -18.6526% | |
| 14.3749% | |
| 55.0273% | |
| 2,109.7973% | |
| -11.3772% | |
| 241.9795% | |
| 202.5391% | |
| -57.0291% | |
| 0% |